-
SLAs to issue manufacture/sale licenses for AYUSH formulations only after approval from AYUSH Ministry
expresspharma
August 03, 2020
The move aims to generate proof of effectiveness for new indications and curb down the false claims associated with AYUSH-related research treatment mechanism.
-
Moderna begins Phase 3 trials of its COVID-19 vaccine candidate
expresspharma
July 28, 2020
The randomised, placebo-controlled trial is expected to include approximately 30,000 participants in the US.
-
Celltrion begins Covid-19 human clinical trial with antiviral antibody treatment
pharmaceutical-business-review
July 21, 2020
Celltrion Group has commenced phase 1 human clinical study to assess the potential of its antiviral antibody treatment for patients with Covid-19.
-
Creative Medical Technology Completes AmnioStem Preclinical Studies
americanpharmaceuticalreview
July 21, 2020
Creative Medical Technology announced completion of preclinical studies assessing the anti-inflammatory and neuroregenerative activities of AmnioStem™.
-
TXA127 from Constant Therapeutics Tested in COVID-19 Trials
americanpharmaceuticalreview
July 20, 2020
Constant Therapeutics announced its peptide drug TXA127 will be tested in a series of Phase 2 clinical trials in hospitalized COVID-19 patients who are not in the Intensive Care Unit (ICU).
-
China’s Sinopharm begins late stage trial of COVID-19 vaccine in UAE
expresspharma
July 20, 2020
The human trial is a partnership between Sinopharm’s China National Biotec Group (CNBG), Abu Dhabi-based artificial intelligence and cloud computing company Group 42 (G42) and the Abu Dhabi Department of Health.
-
Zydus receives approval from COFEPRIS to conduct clinical trials for COVID-19 treatment therapy
expresspharma
July 20, 2020
Zydus had earlier approached the DCGI to investigate the role of Pegylated Interferon alpha-2b for COVID 19 and the clinical trials are now underway.
-
AIIMS Ethics Committee gives nod to human clinical trial of Covaxin
expresspharma
July 20, 2020
AIIMS-Delhi is among the 12 sites selected by the Indian Council for Medical Research (ICMR) for conducting phase I and II human trials of Covaxin.
-
Russian scientists hail results of COVID-19 vaccine trial
expresspharma
July 17, 2020
Speaking to a crowded room without wearing masks, three of 18 volunteers monitored over a month at the Sechenov University said they all had experienced few side-effects.
-
World’s first phase III clinical trial of COVID-19 inactivated vaccine begins in UAE
expresspharma
July 17, 2020
H.E. Sheikh Abdullah bin Mohammed Al Hamed, Chairman of Department of Health, Abu Dhabi is the first to participate in the vaccination trial.